|1.||Khosla, Chaitan: 3 articles (08/2014 - 03/2005)|
|2.||Kim, Se-Kwon: 3 articles (05/2014 - 01/2011)|
|3.||Thomas, Noel Vinay: 3 articles (05/2014 - 01/2011)|
|4.||Zhou, Jianping: 3 articles (12/2007 - 07/2006)|
|5.||Liu, Shiguang: 3 articles (12/2007 - 07/2006)|
|6.||Quarles, L Darryl: 3 articles (12/2007 - 07/2006)|
|7.||Mobashery, Shahriar: 3 articles (04/2006 - 10/2002)|
|8.||Fridman, Rafael: 3 articles (04/2006 - 10/2002)|
|9.||Swarnakar, Snehasikta: 2 articles (01/2015 - 01/2015)|
|10.||McKee, Marc D: 2 articles (01/2013 - 12/2002)|
|1.||Celiac Disease (Celiac Sprue)
12/01/2008 - "Protein engineering of improved prolyl endopeptidases for celiac sprue therapy."
03/08/2005 - "Prolyl endopeptidases (PEPs) are a unique class of serine proteases with considerable therapeutic potential for the treatment of celiac sprue. "
12/01/2011 - "Bile acids deactivate certain enzymes, such as prolyl endopeptidases (PEPs), which are investigated as candidates for protease-based therapy for celiac sprue. "
05/31/2011 - "To establish the proof of principle, the assay was applied to proline-specific endopeptidases (PEPs), a group of enzymes recently proposed as adjuvant therapy for celiac disease (a highly prevalent immunogenetic enteropathy). "
12/01/2008 - "Due to their unique ability to cleave immunotoxic gluten peptides endoproteolytically, prolyl endopeptidases (PEPs) are attractive oral therapeutic candidates for protecting celiac sprue patients from the toxic effects of dietary gluten. "
09/01/1996 - "Improvement in pulmonary function after preservation and reperfusion with a neutrophil endopeptidase inhibitor confirms the role of endopeptidases in reperfusion injury and suggests an intervention to reduce their detrimental effects on early graft function."
09/01/1996 - "We hypothesized that inhibition of these neutrophi endopeptidases (proteases) would attenuate pulmonary reperfusion injury. "
01/01/2004 - "Recent studies of inherited and acquired hypophosphatemia which exhibit similar biochemical and clinical features, have led to the identification of novel genes, phosphate regulating gene with homologies to endopeptidases on the X chromosome (PHEX) and fibroblast growth factor-23 (FGF-23), that play a role in the regulation of Pi homeostasis. "
03/01/1998 - "Two mouse mutations gyro (Gy) and hypophosphatemia (Hyp) are mouse models for X-linked hypophosphatemic rickets and have been shown to be deleted for the 5' and 3' end of the mouse homolog of PHEX (phosphate regulating gene with homologies to endopeptidases on the X chromosome; formerly called PEX), respectively. "
12/01/2007 - "X-linked hypophosphatemia (XLH) is characterized by hypophosphatemia and impaired mineralization caused by mutations of the PHEX endopeptidase (phosphate-regulating gene with homologies to endopeptidases on the X chromosome), which leads to the overproduction of the phosphaturic fibroblast growth factor 23 (FGF23) in osteocytes. "
07/01/2005 - "The X-linked hypophosphatemia (XLH), the most common form of hereditary rickets, is caused by loss-of-function mutations of PHEX (phosphate-regulating gene with homology to endopeptidases on the X chromosome) leading to rachitic bone disease and hypophosphatemia. "
11/01/2012 - "Dentin matrix protein-1 (DMP1) or phosphate-regulating gene with homologies to endopeptidases on the X chromosome (PHEX) inactivation results in elevation of the phosphaturic hormone fibroblast growth factor (FGF)-23, leading to hypophosphatemia, aberrant vitamin D metabolism, and rickets/osteomalacia. "
|4.||Wounds and Injuries (Trauma)
02/01/2011 - "Matrix metalloproteinases (MMPs) are endopeptidases that degrade extracellular matrix and involved in ischemic organ injuries. "
01/23/2009 - "Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases involved in brain development and the etiology of adult cerebral injuries. "
04/01/2008 - "Matrix metalloproteinases (MMPs), a large family of zinc-dependent endopeptidases, have been shown to have increased activity in chronic wound fluid (CWF), with many authors suggesting that they need to be inhibited for the ulcer to heal. "
08/01/2005 - "To evaluate the effect of a hydrogel wound dressing containing a combination of endopeptidases on pressure ulcers, a 12-week prospective preliminary study was conducted involving 10 nursing home patients with Stage II (n = 3) or Stage III (n = 7) ulcers that had failed to respond to previous treatments. "
10/15/1988 - "Putative endopeptidases of subunit Mr 112000, 78,000, 53,000, and in some experiments 88,000 and 16,000, were trapped by alpha 2M in supernatant fractions from IMR90 human fibroblasts, EBTr bovine fibroblasts and HeLa human carcinoma cells. "
05/16/1996 - "As thyroglobulin expression is frequently altered in thyroid carcinomas, we have analyzed 42 human thyroid tissues from 40 patients to study the effect of malignant transformation an the expression of these endopeptidases. "
12/07/2004 - "Collagenase-3 (MMP13), a member of the matrix metalloproteinase (MMP) family of neutral endopeptidases, is expressed in the skeleton during embryonic development and is highly overexpressed in human carcinomas and in chondrocytes and synovial cells in rheumatoid arthritis and osteoarthritis. "
01/12/2011 - "These peptides also selectively inhibited the enzymatic activities of prolyl-amino-peptidases, prolyl-amino-dipeptidases, and prolyl-endopeptidases in extracts of HT-29 and SW480 human colon carcinoma cells, but not in intact cells. "
|6.||Peptide Hydrolases (Proteases)
|7.||Matrix Metalloproteinase 9 (Gelatinase B)
|9.||Proteins (Proteins, Gene)
|2.||Home Nursing (Nursing, Home)
|3.||Hematopoietic Stem Cell Mobilization